Grading of Tumor Regression in Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Grading of Tumor Regression in Non-small Cell Lung Cancer

Published:2001-11 Issue:5 Volume:120 Page:1584-1591
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Junker Klaus,Langner Kathrin,Klinke Folker,Bosse Ulrich,Thomas Michael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference23 articles.

1. Revisions in the international system for staging lung cancer;Mountain;Chest,1997

2. Combined modality treatment for locally advanced non-small cell lung cancer;Johnson,1996

3. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small cell lung cancer;Choi;J Clin Oncol,1997

4. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805;Albain;J Clin Oncol,1995

5. Tumour regression in non-small cell lung cancer following neoadjuvant therapy: histological assessment;Junker;J Cancer Res Clin Oncol,1997

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IASLC grading system predicts distant metastases for resected lung adenocarcinoma;Journal of Clinical Pathology;2024-08-21

2. Perioperative Predictive Factors for Tumor Regression and Survival in Non-Small Cell Lung Cancer Patients Undergoing Neoadjuvant Treatment and Lung Resection;Cancers;2024-08-20

3. Pathologische Diagnostik und Biomarker für die perioperative Systemtherapie;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2024-08

4. Radiolabeled anti-PD-L1 peptide PET/CT in predicting the efficacy of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer;2024-07-26

5. Immune checkpoint inhibition in early-stage non-small cell lung cancer;Lung Cancer;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3